Lung cancer is associated with a high mortality, with around 1.8 million deaths worldwide in
2018. Non-small-cell lung cancer (NSCLC) accounts for around 85% of cases and, despite …

Abstract Background Long noncoding RNAs (lncRNAs) are known to regulate tumorigenesis
and cancer progression, but their contributions to non-small-cell lung cancer (NSCLC) …

Non-small cell lung cancer is the most common type of cancer with a poor prognosis, and
development of an effective diagnostic method is urgently needed. Exosomal lncRNAs, a …

While estrogen receptor β (ERβ) may impact the progression of non-small cell lung cancer
(NSCLC), its linkage to alteration of the vasculogenic mimicry (VM) formation to influence the …

The lncRNA PVT1 has emerged as a pivotal component in the intricate landscape of cancer
pathogenesis, particularly in lung cancer. PVT1, situated in the 8q24 chromosomal region …

Long noncoding RNAs (lncRNAs) are implicated in human cancer, but their mechanisms of
action are largely unknown. In this study, we investigated lncRNA alterations that contribute …

Lung cancer is the leading cause of cancer death in the world and there is no current
treatment able to efficiently treat the disease as the tumor is often diagnosed at an advanced …

Background. Cervical cancer is one of the most frequent malignancies among females
worldwide. Increasing evidence have indicated the participation of long noncoding RNAs …

Background/Aims: Plasmacytoma variant translocation 1 (PVT1) exerts an oncogenic role in
many tumors, including lung cancer. However, the roles of PVT1 in regulating …

The plasmacytoma variant translocation 1 (PVT1) is a long non-coding RNA gene involved
in human disease, mainly in cancer onset/progression. Although widely analysed, its …